These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16217017)

  • 1. Dynamic effects of antibody-dependent enhancement on the fitness of viruses.
    Cummings DA; Schwartz IB; Billings L; Shaw LB; Burke DS
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15259-64. PubMed ID: 16217017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.
    Chaichana P; Okabayashi T; Puiprom O; Sasayama M; Sasaki T; Yamashita A; Ramasoota P; Kurosu T; Ikuta K
    PLoS One; 2014; 9(3):e92173. PubMed ID: 24642752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.
    Wang M; Yang F; Huang D; Huang Y; Zhang X; Wang C; Zhang S; Zhang R
    Front Cell Infect Microbiol; 2017; 7():157. PubMed ID: 28536674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Slike BM; Burgess TH; Mason RM; Wu SJ; Sun P; Porter K; Rudiman IF; Yuwono D; Puthavathana P; Marovich MA
    J Virol; 2008 Apr; 82(8):3939-51. PubMed ID: 18272578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
    Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ
    PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.
    de Alwis R; Williams KL; Schmid MA; Lai CY; Patel B; Smith SA; Crowe JE; Wang WK; Harris E; de Silva AM
    PLoS Pathog; 2014 Oct; 10(10):e1004386. PubMed ID: 25275316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking the symmetry: immune enhancement increases persistence of dengue viruses in the presence of asymmetric transmission rates.
    Mier-y-Teran-Romero L; Schwartz IB; Cummings DA
    J Theor Biol; 2013 Sep; 332():203-10. PubMed ID: 23665358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains.
    Kawaguchi I; Sasaki A; Boots M
    Proc Biol Sci; 2003 Nov; 270(1530):2241-7. PubMed ID: 14613610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection.
    Narayan R; Tripathi S
    Front Cell Infect Microbiol; 2020; 10():580096. PubMed ID: 33123500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaotic desynchronization of multistrain diseases.
    Schwartz IB; Shaw LB; Cummings DA; Billings L; McCrary M; Burke DS
    Phys Rev E Stat Nonlin Soft Matter Phys; 2005 Dec; 72(6 Pt 2):066201. PubMed ID: 16486034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.
    Shukla R; Ramasamy V; Shanmugam RK; Ahuja R; Khanna N
    Front Cell Infect Microbiol; 2020; 10():572681. PubMed ID: 33194810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
    Guy B; Chanthavanich P; Gimenez S; Sirivichayakul C; Sabchareon A; Begue S; Yoksan S; Luxemburger C; Lang J
    Vaccine; 2004 Sep; 22(27-28):3563-74. PubMed ID: 15315835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zika Virus Replication in a Mast Cell Model is Augmented by Dengue Virus Antibody-Dependent Enhancement and Features a Selective Immune Mediator Secretory Profile.
    Coish JM; Crozier RWE; Schieffelin JS; Coorssen JR; Hunter FF; MacNeil AJ
    Microbiol Spectr; 2022 Aug; 10(4):e0177222. PubMed ID: 35862953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tetravalent dengue vaccination with screening, ADE, and altered infectivity on single-serotype dengue and Zika transmission.
    Kribs C; Greenhalgh D
    J Math Biol; 2023 Apr; 86(5):85. PubMed ID: 37119296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus.
    Renner M; Flanagan A; Dejnirattisai W; Puttikhunt C; Kasinrerk W; Supasa P; Wongwiwat W; Chawansuntati K; Duangchinda T; Cowper A; Midgley CM; Malasit P; Huiskonen JT; Mongkolsapaya J; Screaton GR; Grimes JM
    Nat Immunol; 2018 Nov; 19(11):1248-1256. PubMed ID: 30323338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue.
    Adams B; Boots M
    J Theor Biol; 2006 Sep; 242(2):337-46. PubMed ID: 16631802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus.
    Ripoll DR; Wallqvist A; Chaudhury S
    Front Cell Infect Microbiol; 2019; 9():200. PubMed ID: 31275864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Dambach KM; Donofrio GC; Tassaneetrithep B; Marovich MA
    J Virol; 2011 Feb; 85(4):1671-83. PubMed ID: 21123382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection.
    Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF
    Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.